
Constellation Pharmaceuticals set terms for its planned initial public offering on Monday, saying it will offer 5.34 million shares priced at $14 to $16 each. The company would raise $80.1 million at the midpoint of the range. The clinical stage biotech, which is focusing on meeting unmet medial needs in patients with cancers caused by […]